# Filing Detail

Form DEFC14A - Definitive proxy statement, contested solicitations:
SEC Accession No. 0001140361-22-026309
Filing Date
2022-07-19
Accepted
2022-07-19 08:01:58
Documents
4

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFC14A | edge20002003x4_defc14a.htm | DEFC14A | 1163385
2 |  | edge20002003x4_pc01.jpg | GRAPHIC | 857890
3 |  | edge20002003x4_pc02.jpg | GRAPHIC | 965290
4 |  | logo_dfkingast2.jpg | GRAPHIC | 30241
| Complete submission text file | 0001140361-22-026309.txt |  | 3716830

Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filed by) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: DEFC14A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: DEFC14A | Act: 34 | File No.: 000-51173 | Film No.: 221090419
SIC: 2834 Pharmaceutical Preparations